Immune Checkpoint Inhibitors Combined With Chemotherapy Compared With Chemotherapy Alone for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: It is still controversial whether immune checkpoint inhibitors (ICIs) can improve the curative effect when added to original standard chemotherapy treatment for triple-negative breast cancer (TNBC). We compared their antitumor efficacy and adverse effects (AEs) to make a better clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Qiao, Ding, Jingxian, Hao, Meiqi, Luo, Nachuan, Huang, Jiabing, Zhang, Wenxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716854/
https://www.ncbi.nlm.nih.gov/pubmed/34976837
http://dx.doi.org/10.3389/fonc.2021.795650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716854/
https://www.ncbi.nlm.nih.gov/pubmed/34976837
http://dx.doi.org/10.3389/fonc.2021.795650

Ejemplares similares